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With society getting older and affected by many  diseases, more and more people suffer from
severe cognitive disorders. As practice shows, the legal situations of such people is often
problematic. This is due to a number of factors, such as short time since the deterioration of
patient’s condition, initial symptoms ignored, social prejudice towards the idea of incapaci-
tation or taking decisions for a patient, complicated procedures and, sometimes, insufﬁcient
knowledge of legal regulations. Cognitive disorders also occur in patients treated for cancer.
To  be effective, oncological treatment needs to be started as early as possible. This, however,
does not meet the criteria of sudden threat to life. The present article relates to both the
psychosocial and legal aspects of care of people suffering from intense disorders of memory,
attention, problem solving, executive functions, and other. Surely, physicians know how to
handle patients with the above dysfunctions. However, legal procedures aimed to protect
patients’ rights are often unclear and time consuming. In practice, this often amounts toa  dilemma whether to treat or follow the applicable law. Certainly, solutions in this regard
should be clearer and better adapted to the needs arising from speciﬁc treatment needs of
particular groups of patients.
©  2013 Published by Elsevier Urban & Partner Sp. z o.o. on behalf of Greater Poland Cancerognitive impairment is a group of symptoms that often
ccur in patients treated for oncological diseases. Among
hese, are those who,  due to cancer, experience sudden
ymptoms of brain damage, and those treated for cancers
f different locations who have a history of brain damage
r any sort of neurodegenerative disease. Such disorders
ay develop for months or even years, with effects cov-
ring virtually all functions. Cognitive dysfunctions also
pply to patients treated psychiatrically, e.g. for affective
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disorders. Moreover, they may occur temporarily as symp-
toms of other somatic diseases or as a side effect of surgery,
radiation therapy, chemotherapy or drugs applied in those
therapies.1–3 In many  cases, they present as mild cogni-
tive impairment, but sometimes make it very difﬁcult to
make a contact or exchange information with patients and
prevent them from functioning by their own, including tak-
ing important decisions, such as those to start or continue
treatment.4.o. on behalf of Greater Poland Cancer Centre.
d rad158  reports of practical oncology an
1.  Psychosocial  and  medical  aspects  of
oncological  treatment  of  patients  with  cognitive
impairment
Diagnosing cognitive dysfunctions in patients is of utmost
importance, particularly when they are subjected to a long-
term and traumatic treatment, as oncological treatment
surely is. It is signiﬁcant for medical reasons, as an important
symptom that helps determine optimal treatment modality,
to assess possibilities of cooperating with the patient, but also
in view of the need to respect the existing legal regulations.
A detailed interview concerning patient’s life so far might
prove very helpful here. Information is gathered mostly from
patients themselves so as to obtain a preliminary picture of
their difﬁculties in cognition, memory,  thinking and speech,
and then, in the second instance, from their caretakers. An
essential role in the process is played by psychiatric consulta-
tion supported by a neuropsychological evaluation of cognitive
function using test methods to deliver more  detailed informa-
tion in this regard. The most commonly used methods include:
Wechsler Adult Intelligence Scale (WAIS-R(PL)) and Wechsler
Intelligence Scale for Children (WISC-R(PL)), Right Hemisphere
Language Battery (RHLB-PL), Boston Diagnostic Aphasia Exam-
ination (BDAE), a set of tests for patients brain damage, Bright
Vision Therapeutic Riding (BVTR), Rey-Osterrieth Complex
Figure, Auditory Verbal Lerning Test, Mini-Mental State Exam-
ination (MMSE), Clock Drawing Test (CDT), Verbal Fluency Test,
Trail Making Test (TMT).5,6
The psychopathological conditions which are typical
for cognitive impairment and which are most commonly
diagnosed in cancer patients include: impairment of con-
sciousness, dementia, depression and focal brain damage.
Cognitive disorders are general dysfunctions of the central
nervous system which often occur suddenly and are poten-
tially transient and reversible in nature. The literature divides
conditions of impaired consciousness into quantitative and
qualitative ones. The quantitative disorders include: clouding
of consciousness, where a verbal contact with the patient is
possible but limited to answers to simple questions due to
a reduced thinking performance and coherence and uncer-
tain orientation to time and place; or somnolence, semicoma
and coma where the patient does not respond to any verbal
or physical stimuli, their reﬂexes gradually disappearing. The
qualitative category comprises: delirium, which may be the
most common symptom of cognitive function deterioration
in patients with somatic diseases; oneiroid syndrome which
presents with hallucination and complex and severe memory
disorders; obnubilation characterised by a total disorientation
and disorders of perception, problem solving and psychomo-
tor activity (slow-down or acceleration); as well as mental
confusion with distinct and intense disturbance of auto and
allopsychical orientation, train of thought, memory and ver-
bal contact, and motor restlessness. Mental confusion mostly
arises from patient’s poor somatic condition.7–9 As mentioned
before, the most commonly occurring type of consciousness
disorder in somatic patients, including those treated for can-
cer, is delirium. The deﬁnition contained in the International
Classiﬁcation of Diseases (ICD-10), identiﬁes such symptoms as
disturbances of consciousness manifested by various sorts ofiotherapy 1 9 ( 2 0 1 4 ) 157–164
difﬁculties in recognising the environment; limited ability to
focus, maintain and re-direct attention; and disorders of cog-
nitive processes which present primarily with difﬁculties in a
direct and short-term memory,  with relatively well-preserved
long-term memory.  Usually, confusion of time, place and/or
person is also observed. Those symptoms are accompanied
by psychomotor disorders, such as reduced or intensiﬁed
activity, extended or intensiﬁed reaction of surprise, rapid
or slowed speech. Frequently observed are also disturbances
in the sleep-wake cycle and a varied intensity of the symp-
toms during the day, e.g. stronger disorders in the evening
or at night and a much better performance at daytime.10
Sometimes, changes occur and disappear within minutes. It
is important to identify the background of the symptoms, as
they can go in pair with life-threatening disease processes,
such as stroke, increase of intracranial pressure, encephalitis
and other.7 As much as impaired consciousness is symp-
tomatic of many  diseases, the determination of its etiological
background may prove difﬁcult. Also in oncological patients
treated with surgery, radio- and/or chemotherapy or other
modalities, the identiﬁcation of the reasons for rapidly grow-
ing symptoms is a problematic task, as they may be associated
with many  factors, directly preceding the disorders of con-
science. These include: physical immobility, catheterisation,
malnutrition, dehydration, a number of drugs and risk factors
of a chronic nature, e.g. side effects of treatment, somatic dis-
eases, conditions associated with acute pain, and many  more.7
It needs also to be borne in mind that disorders of consci-
entiousness are common symptoms in a variety of old-age
diseases, and elderly people, as mentioned before, represent a
large proportion of cancer patients. Therefore, distinguishing
disorders of consciousness from cognitive impairment result-
ing from dementia may be a challenge, particularly at the ﬁrst
or single contact with the patient. The main distinguishing
trait is the duration of the symptoms.9
In dementia alike the main symptoms are memory  dis-
orders, applying particularly to the direct, short-term and
operating memory,  attention and learning processes. How-
ever, the course and dynamics of the changes are different.
The onset of dementive disorders is hard to discern, as this
type of dysfunction advances very slowly as a long-term pro-
cess contrary to impairments of consciousness which usually
turn up suddenly and persist for some ten to twenty days.9
Dementia usually affects thinking-reduced level of general-
isation (disturbance in abstract thinking) and difﬁculty in
executive functions, such as motivation, planning, coordina-
tion and control of actions and emotions. With symptoms
highly intensiﬁed, the patient might ﬁnd it difﬁcult to answer
questions concerning time and place or related to themselves
or people from their close circle. Dementive disorders occur for
instance in Alzheimer’s disease, cardiovascular diseases and
other diseases affecting the cerebral circulation, Lewy bod-
ies dementia, or due to frontotemporal degeneration. They
may also result from focal injuries and other focal damage
or the activity of toxic agents. In contrast to disorders of con-
sciousness, dementia is irreversible and deepening in time,
although the course of the disease may vary depending on
the cause: primary degenerative processes will differ from
dementia induced by a vascular process, toxic agent or injury
(spurting progression, often marked with a sudden onset).8–10
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ince the development of dementia symptoms is often slow, it
ends to go unnoticed with symptoms difﬁcult to understand
s they appear.
Depressive disorders, as syndromes of different aetiol-
gy, are widely described in literature.8,11 This article focuses
ather on cognitive disorders that stem from them. Most
ommonly reported are issues related to direct, short-term
emory,  delayed recall of memorised material, attention,
rain (slow-down) of thought and executive functions. The
everity of symptoms varies, although mostly presents with
ild cognitive impairment.11,12 The functioning of the patient
ay be affected by both the improvement or worsening
f mood, however, in oncological patients mood is mostly
bserved to be down. It needs to be remembered that mood
isorders, especially deterioration of mood, is a common
ymptom with certain types of damage to the central nervous
ystem (e.g. to the basal and medial frontal lobes)13,14 (Table 1).
Another group of disorders occurring in oncological
atients are focal damages where the type and intensity of
ognitive dysfunctions depend on the site and size of the
esion. They can, but do not need to, affect the ability to
unction independently and take decisions. Sometimes, the
ssence of disorders is hard to capture. The difﬁculties expe-
ienced by the patient may be strongly affected by their
re-disease level of functioning. Evaluating the dysfunction
ay be complicated due to speech disorders, concomitant
aresis and peripheral issues, e.g. those involving the sight
nd hearing. In some patients, part of the cognitive difﬁcul-
ies subside in time causing their functioning to improve. In
ther cases, the dementive process may develop.14,15 A partic-
lar focus should be given to disorders of mnestic processes
mainly short-term and operative memory,  as well as orienta-
ion to time and place), attention, learning, problem solving
nd abstracting, aphasia due to the ability to understand
peech and communicate verbally, or executive functions,
ncluding those related to planning, predicting consequences
nd controlling one’s behaviour. Individuals with such dys-
unctions may be assumed to be able to function or take
ecisions on their own. As regards other most common ways
f communicating with the patient, the ability to read and
rite should also be assessed. Those skills may be limited or
one as a result of memory  deﬁcit and visual gnosia (recogni-
ion of letters, meaning of words and graphic representation of
ords), vision ﬁeld restriction of spatial, executive or attentive
ature (unilateral neglect).10,14,16
Other symptoms, which are of less prevalence in onco-
ogical patients but must not be overlooked, include mental
etardation and schizophrenia.
Mental retardation is caused by inborn factors or developed
t an early stage of life. For that reason, the presentation of
isorders is relatively steady, although it can be modiﬁed by
iseases occurring in the course of life or ageing-related pro-
esses. These often lead to a general reduction of cognitive
unctioning. Difﬁculties in thinking and abstracting come to
he forefront in this regard. Mental retardation is diagnosed
ased on psychological tests to determine the intelligence
uotient (Wechsler Adult Intelligence Scale, Wechsler Chil-
ren Intelligence Scale).10 The ability to function and take
ecisions independently varies considerably based on thetherapy 1 9 ( 2 0 1 4 ) 157–164 159
intensity of a dysfunction (mild, moderate, severe and pro-
found).
Schizophrenia, as many  studies show, is a condition where
cognitive functions, much more  often than in healthy peo-
ple, are disturbed to a varied extent affecting the ability
to evaluate situations and take decisions. The process is
further complicated by productive symptoms, disorganisa-
tion of activities and dysphoria. Cognitive impairment in
schizophrenia patients are observed regardless of the clinical
presentation and duration of untreated disease. Dysfunctions
may occur already in the period preceding the ﬁrst episode of
schizophrenia. They become more  severe not so much with
the duration of the disease as with the age of the patient. A
signiﬁcant deterioration of the functioning has been observed
in patients above 65 years of age. They have been found to
show reduction in executive functions and cognitive processes
responsible for the processing of complex information.8,11,17,18
Deterioration of the cognitive function is a very difﬁcult
experience. Many  cancer patients, particularly those treated
with chemo-, radio- or hormonotherapy, report the occurrence
of cognitive deﬁcits which are typically mild and temporary.
Very often, emotions at the moment of cancer diagnosis are
strong enough to disrupt the functioning of attention, memory
or other functions. Many patients who are not diagnosed with
any cognitive impairment report difﬁculties in remembering
the information provided by the doctor. Therefore, it is very
important to check what the patient actually understood and
remembered.19,20 Boykoff et al. examined a group of 74 women
treated for breast cancer who had ﬁnished their adjuvant ther-
apy (chemo- and/or radiotherapy) at least a year before. Some
of them were in the process of hormonotherapy. As many  as
70% complained about various kinds of dysfunction related
to the cognitive area. The patients described their symptoms
as destabilising, frustrating, alarming. In some of the women,
the disorders led to reduced independence, including ﬁnan-
cial, lost of previous social functions, difﬁculties in resuming
employment, completing study, loss of authority in their fam-
ilies or among friends.2 In patients who have experienced
a sudden brain damage, especially when combined with a
substantial reduction in various aspects of memory,  learn-
ing, problem solving, speech or other cognitive functions, the
life line is suddenly broken. All of a sudden, one loses con-
trol of one’s own life, falling into confusion and despair. The
situation of people who retain their ability of critical thinking
and awareness seem to be particularly difﬁcult emotionally.
On the other hand, patients suffering from progressive dis-
eases, such as Alzheimer’s disease and vascular dementia,
need to face the process of gradual worsening of their perfor-
mance and independence, a perspective of losing control over
their own life, growing dependence upon other people and
the sense of being a burden to their beloved ones and friends.
What those two groups of patients have in common is that
changes occurring in their way of functioning (whether sud-
den or progressive) apply not only to themselves. They reach
much further, affecting the life of the whole family.19 But the
impact reaches beyond the family, too, to members of thera-
peutic teams in clinics and oncology departments as they can
experience difﬁculties arising from patient’s disturbed func-
tioning. First, noticing dysfunction in the areas of orientation,
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Table 1 – Disorders of consciousness versus dementia and depressive disorders [by Wells 1979 and Ham et al. 1997].8
Disorders of consciousness Dementia Depressive disorders
Sudden, often clearly identiﬁable onset, Gradual onset, hard to identify, Complaints about memory disorders,
Concurrent signiﬁcant medical factors, Gradual intensiﬁcation over months, years, Frequently reported prior depressive
disorders,
Duration: days – less often weeks, Duration: months, years, “I don’t know” is a common answer at
interview,
Usually reversible, Usually irreversible, often progressive process, Memory and recall are similarly impaired,
Early disorientation, Disorientation at a late stage, Depressive mood usually precedes other
symptoms associated with the cognitive
area.
High variability of the presentation/in
particular hours, days/,
Relatively stable presentation (in particular
days),
Clear physiological changes, Less distinct physiological changes,
Variable level of consciousness, No disorders of consciousness,
Heavy reduction of attention, No signiﬁcant changes in attention in clinical
examination,
Disturbance of the hourly sleep-wake
rhythm,
A  shift or reversal of a daily sleep-wake
rhythm,
Large psychomotor changes, Psychomotor disorders become worse in the
course of disease.
Lack of perceived memory disorders,
Frequent absence of reported
psychopathological disorders,
Answers are often “close to the truth”,
More severe memory disorders,
Memory dysfunctions are among the ﬁrst
symptoms.
memory,  understanding, problem solving or even speech may
be difﬁcult, particularly within a short time. Then, doctors may
be tempted to ignore the above symptoms to implement onco-
logical treatment as soon as possible acting in patient’s ‘best
interest’. However, such symptoms are likely to be predictive
of the deterioration of patient’s health status and, therefore,
taking them into consideration and implementing appropri-
ate treatment may be of great importance for the success of
the therapy.7,10 One also has to remember about the need to
maintain a humanitarian approach towards the patient and
to respect their rights, including the right to decide about
themselves.5,20
Taking decision is of adaptive value for individuals and,
as such, requires them to be able to integrate sensory infor-
mation, motivate themselves and predict potential effects
of their actions. In psychology, taking decisions is described
as a process made up of cognitive, emotional and motiva-
tional components. The process may be divided into three
phases: the pre-decision phase where a problem is deﬁned
and information collected about possible actions to be taken;
the decision-making phase where the leading option is gradu-
ally identiﬁed and ﬁnal decision taken; and the post-decision
phase which involves the evaluation of the choice made. In
1956, Simon designed a theory of limited rationality which has
become the foundation of the current approach to decision-
making processes. According to that theory, individuals take
decisions which are aimed to help them adapt to the envi-
ronment, but in doing so they have a limited information
about the environment they live in and limited possibilities
of processing that information. Of note is also the so-called
‘framing effect’ described by Kahneman and Tversky in 1979.
The authors argue that a mental representation of the deci-
sion problem (which certainly dependents on the efﬁciencyof cognitive system), largely determines the human decision
making process.4 This shows that the way of perceiving and
solving the problem is inﬂuenced by a number of factors of
both external (e.g. understanding of the ‘language code’, infor-
mation noise) and internal nature. Creating perfect conditions
for decision making is essential for an individual’s further
emotional functioning. This relates to the sense of having con-
trol over oneself. To restore this sense of control is one of the
objectives that oncology psychologists focus on. Observations
show that a person who is deprived of signiﬁcant information
or the possibility to decide ﬁnds it much harder to adapt to
a new difﬁcult situation. They may try to pass the responsi-
bility to others, “because it was not by their choice, after all,
and it is the deciding person that holds the responsibility for
the effects”. This approach can also be seen in individuals who
have started treatment against their will, under a strong inﬂu-
ence of their families. Inability to decide about oneself gives
rise to the frustration of one of human basic needs, which may
lead to the worsening of mood, anger and aggression.21–24 That
is why, every human must be given a chance to have an impact
on their own life. Should this be very difﬁcult or impossible due
to cognitive impairment or other factors, it is of great impor-
tance that affected individuals are supported and protected in
such a way that someone else (be it court, care-takers or fam-
ily) could participate in the process. This purpose is served by
speciﬁc legal solutions.
2.  Legal  aspects  of  treating  patients  with
cognitive  disorders
From the legal point of view, cognitive disorders are often
combined with the inability to give a valid consent for being
reports of practical oncology and radiotherapy 1 9 ( 2 0 1 4 ) 157–164 161
Table 2 – Kind of agreements on treatment.
Own consent Parallel consent Substitute consent
- taken by the patient themselves, adult
and not incapacitated (partly or
entirely)
-  taken both by the patient and another entity, - taken on patient’s behalf by another
person or institution
- taken by a woman who is above 16 years
of age and legally married,
-  in the case of contradictory decisions, the
consent for treatment may not be deemed to
be valid,
- used for example in the case of patients who
are above 16 years of age (additional consent
of a statutory representative is required)
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(Source: own study based on the Act of 5 December 1996 on Profession
rovided medical services. A possibility to agree to (or refuse)
edical treatment is one of patient’s essential rights, guar-
nteed by the Act on Patient Rights and Patient Ombudsman
f 6 November 2008 (Journal of Laws from 2009 No. 52(417)
s amended). The issue of consent is speciﬁcally regulated by
he Act on Professions of Doctor and Dentist of 5 December
996 (Journal of Laws from 2011 No. 277(634) as amended)
y specifying doctors’ obligations in this regard. That right
ay also be derived from the Constitution which, in its Arti-
le 41, guarantees freedom and physical integrity to all and,
ith Poland’s being a party to the Convention for the Pro-
ection of Human Rights and Dignity of the Human Being
ith regard to the Application of Biology and Medicine, the
rticle 5 of that Convention prohibiting medical interven-
ion without patient’s free and informed consent should also
e taken into account. Those legal acts are further supple-
ented by the Medical Code of Ethics which, in its Article
5, imposes the duty to respect patient’s will in the treatment
rocess.
The aforementioned laws  and professional standards illus-
rate a far-reaching transition of the relations between the
octor and the patient. There has been a clear departure from
he once dominant paternal concept to the rule of partnership,
hereby the patient co-decides about the length and scope of
reatment. In consequence, the doctor is required to inform
he patient of the disease status, method of treatment, equiv-
lent treatment methods and possible complications in such a
ay as to enable them to understand each stage of treatment
nd consequences of their refusal to be treated. The attending
octor is responsible for assessing to what extent the patient
s able to understand the information provided to them. This
ay involve the necessity to spend more  time or use the assis-
ance of another specialist to provide the information properly.
nly then does patient’s consent authorise the doctor to act,
hile setting the limits and conditions of the accepted medical
ntervention.20,25
Depending on whether the consent is given personally by
he patient or by another person acting on their behalf, the
ollowing types of consents may be distinguished (Table 2):
Informed consent may only by given by the patient whose
ealth status enables them to understand information pro-
ided by the doctor and take, according to the information
eceived, a decision allowing or not speciﬁc medical actions
o be taken.25 What is more,  not every consent given by the
atient is correct. A consent improperly given is legally invalid
nd thus involving patient’s civil or criminal liability. A properoctor and Dentist.
consent for treatment must meet all of the following condi-
tions:
a) received before the onset of a medical action,
b) well informed, that is preceded by doctor’s information as
set out in Article 31(1) of the Act on Professions of Doctor
and Dentist,
(c) expressed in an appropriate form (a consent for surgi-
cal procedures, medical procedures and other activities of
high risk must be given in writing),
d) issued by an authorised entity,
(e) positively approved; patient’s silence does not mean
consent.26
It needs to be underlined that law speciﬁes the categories
of patients who are unable to give their consent for medi-
cal intervention. These include minors, incapacitated patients
and patients who are unable to give an informed consent.
The former two categories comprise patients with a de lege
incapability, as minority and incapacitation are determined
by law. The third group are patients who are de facto inca-
pable, as their incapability is caused by factual circumstances
(e.g. patients who are unconscious, mentally ill, intoxicated
with alcohol or drugs).27 It may be assumed that patients with
cognitive disorders will mostly fall into the third category.
Pursuant to Article 32(2) Act on Professions of Doctor and
Dentist, in the case of a patient unable to give their informed
decision, a permission of their representative is necessary, and
in the absence of such a representative, a consent for medi-
cal intervention issued by the guardianship court (substitute
consent). It should be remembered, however, that diagnosed
cognitive disorders may not be automatically regarded as the
inability to give an informed consent, which happens in med-
ical practice. As an example, one may refer to the general
provisions of the Polish Civil concerning the declaration of
will (it should be borne in mind that a consent for a medical
service is a declaration of will under the Civil Code, subject to
any differences arising from the Act on Professions of Doctor
and Dentist). According to Article 82 of the Civil Code, being
in a state of inability to take an informed decision and declare
one’s free will is a fault of the declaration of will causing it to
be invalid. The case law deﬁnes such a state as the inability
to recognise, the inability to understand one’s own and other
people’s actions and the inability to realise the meaning and
effects of one’s own conduct (sentence of the Supreme Court
of 7 February 2006, IV CSK 7/05 Lex, No. 180191). According
d rad
(a) jurisdiction is held by a district court with competence162  reports of practical oncology an
to another ruling (sentence of the Supreme Court of 30 April
1976, III CRN 25/76 OSP 1977 4(78) “it is, therefore, of decisive
importance to determine the extent of reduced consciousness
in a person’s actions, the level of mental disturbance at the
moment of making the declaration of will”. It is of no relevance
whether the state was of a permanent or temporary nature, as
it is the relation between that state and a speciﬁc declaration
of will that matters.28 What is relevant is that the state occurs
at the moment of making the declaration of will. It should
be stressed that a mere  indication of patient’s being affected
by a mental disease is not enough to deem their declaration
of will to be invalid. On the other hand, the indication that
the declaration was made in the state identiﬁed as exclud-
ing consciousness, causes that declaration to be null and
void.
The Act on Professions of Doctor and Dentist grants some
rights even to incapacitated persons. Pursuant to its Article
32, with regard to persons fully incapacitated, the right to give
consent is awarded to a statutory representative. However, if
the patient is capable of consciously expressing their opin-
ion about treatment, their consent must also be taken into
account.
Moreover, the Act in its Article 32(6) permits an effective
objection to be submitted against medical action being taken
by minors above 16 years of age, incapacitated patients and
the mentally retarded, if they are “sufﬁciently conscious”. In
such cases, the provision of medical services will depend on
the guardianship court permission.
It is worth mentioning at this point what the procedure
of obtaining court permission actually involves. It should be
resorted to in cases when the doctor ﬁnds the patient to be
unable to give their informed consent. The guardianship court
permission is applied for by a family member or doctor. The
jurisdiction is held by a guardianship court of a district court
with competence over the place of residence or stay of the
person to be treated. The application must indicate both the
applicant and the participant, i.e. the patient. A properly com-
pleted application should include the indication of the type
of document (e.g. application for a medical procedure con-
sent); reasons for applying; and necessary relevant supporting
documents; opinions; medical records; description of circum-
stances; and applicant’s signature. The reasons should include
a precise description of who the patient is, what kind of dis-
orders prevent them from giving their informed consent and
how it threatens their life and health. Information of regular
control by a mental health care clinic should also be included,
if available.
With  regard to fully incapacitated individuals, the
guardianship court may only permit a surgical procedure or a
high risk modality or diagnosis. The provision of Article 32(4)
in conjunction with Article 34(3) of the Act on Professions of
Doctor and Dentist imposes a limitation on the court. The lim-
itation in this case seems to be a legal gap that may prevent
the doctor from requesting the court, for example, to permit
examination in the absence of a statutory representative or
inability to communicate with the patient. It is a signiﬁcant
matter as doctors face that issue in their daily practice.
The institution of a full or partial incapacitation allowed by
low in justiﬁed cases calls for a separate discussion. Causes
for full incapacitation may be divided as follows:iotherapy 1 9 ( 2 0 1 4 ) 157–164
- formal: above 13 years of age,
- substantial:
(a) mental disease, mental retardation or other mental disor-
der found in the person concerned,
(b) inability to manage one’s conduct (Article 13 of the Polish
Civil Code). The ﬁrst substantial cause being a prerequisite
for further stages of the procedure.
After the existence of a mental disease, mental retardation
or other mental disorder is proved probable e.g. by submis-
sion of a relevant medical certiﬁcate or witnesses reports, a
court-ordered medical examination may be carried out and
opinion issued by a certiﬁed psychiatrist or neurologist and
psychologist.
As most mental diseases are characterised by periods of
relapse and remission, the Supreme Court has rightly ruled
that the health status at the moment of ruling should be taken
into consideration. The fact of inevitable deterioration of the
health status in the future does not provide grounds for full
incapacitation. Such decision is, however, possible when the
normal mental state is of a temporary nature, while the very
disease is permanent. The court may then rule incapacitation
in the period of remission. In any other cases, e.g. short-term
periods of mental disorders, the occurrence of such disorders
may only constitute a fault of a declaration of will due to the
lack of consciousness rendering the consent to be null and
void.
The above list of causes is of exemplary nature only and has
been in the course of time supplemented by the Polish case
law to include other conditions, such as Senile psychorganic
dementia (sentence of the Supreme Court of 13 January 1975
I CR 787/74 Lex No. 7642). The Supreme Court in its ruling of
25 November 1976 (IICR 471/76, Lex No. 7881) raised that the
arteriosclerotic process alone in the extent according to age
should not be regarded as a mental disease. The mere  fact of
forgetting of the most recent event from daily life, the lack of
plans for the future or being unaware of certain events and
effects do not justify incapacitation. For example, for persons
suffering from Parkinson’s and Alzheimer’s disease, the court
may establish a guardian under Article 183 of the Family and
Guardianship Code.
It should be remembered that the inability to manage one’s
conduct must be permanent rather than temporary. Apart
from mental health, the court evaluates the extent of a given
person’s ability to independently manage their conduct and
matters (the court considers whether such a person has means
to support for themselves or family, how they handle daily
decisions, etc.). The point of incapacitation is to legally protect
the person concerned. The negative reception of that insti-
tution is somewhat surprising then. Notably, the Polish case
law does not modify the causes of incapacitation but rather
highlights the aim of that institution. The Legislator has given
courts some freedom in evaluation of those causes.
The court procedure in incapacitation cases is as follows:over the place of residence or stay of the person concerned.
That court is also competent in the case of previously
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issued rulings being repealed or modiﬁed. Court rulings
are made by four judges,
b) proceedings are initiated on the request of an authorised
person, i.e. spouse, direct relative, sibling or statutory
representative of the person concerned. This autho-
rised group also comprises the prosecutor and social
organisations whose statutory responsibilities include the
protection of persons with disabilities
(c) proceedings may be oral or written,
d) proceedings must include the hearing of the person
concerned in the presence of a certiﬁed psychologist, psy-
chiatrist or neurologist,
e) expert examination (single or multiple) to, be the basis of
the opinion, is also obligatory. The expert opinion and rea-
sons of the application constitutes the basis for the court
decision.
The law does not allow for incapacitation to be established
or a deﬁnite period of time as it should apply as long as the
nderlying disease persists. The court ruling incapacitation
ends a copy of the ﬁnal decision to the guardianship court
n order for it to establish care of the person concerned. If an
ncapacitation request is repealed the civil law court notiﬁes
he guardianship court of the need to appoint a guardian for
he disabled person.
Full incapacitation should be distinguished from partial
ncapacitation the causes of which are as follows:
(a) 18 years of age,
b) mental disease, mental retardation or other mental disor-
der, in particular alcohol or drug abuse, if such a person
may not be fully incapacitated by a court indicating at the
same time that they are in need of assistance to manage
their matters.
A partly incapacitated person, as a person with a limited
egal capacity, may perform on their own all activities other
han related to management or obligation. Viewed from that
erspective, such a person seems to be entitled to give their
onsent for treatment proposed to them.28
Applicable laws, however, in particular Article 33 of the Act
n Professions of Doctor and Dentist, allow an exception from
he absolute rule of patient consent. Those cases relate to
edical treatment or service provided to the patient requir-
ng an immediate medical aid in an urgent matter where,
ue to patient’s health status or age, they are not able to
ive their consent and it impossible to contact their statu-
ory representative or actual guardian. If such circumstance
ccur, the decision to take medical intervention should be
onsulted with another doctor. Such a situation should be
ecorded in patient’s medical documentation. This particular
easure may be applied in exceptional cases, when patient’s
ife or health is threatened. A proper application of this rule
ndemniﬁes the doctor from the responsibility under Article
92(1) of the Polish Criminal Code, whereby who performs a
edical procedure without patient’s consent is subject to a
ne, restriction of liberty or imprisonment of up to 2 years.
The provision of Article 34(7) of the Act on Professions
f Doctor and Dentist provides doctors with an option to
erform surgery or high risk treatment (diagnosis) methodstherapy 1 9 ( 2 0 1 4 ) 157–164 163
without patient’s statutory representative’s consent or with-
out the competent court’s permission, if the delay caused by
the consent procedure might pose a threat to the patient’s
life, physical integrity or health. In that case, the doctor is
also obliged to consult another doctor, preferably of the same
speciality. Statutory representative, actual guardian or com-
petent court need, however, to be immediately notiﬁed of the
procedure performed.
A particular exception is provided by Article 35(1) of the Act
on Professions of Doctor and Dentist which permits the doctor
to legally act without having to re-apply for consent if a mod-
iﬁcation of medical intervention is necessary. The doctor is
entitled to change the scope of surgery, diagnostic or curative
procedure in such a way as to take into account the circum-
stances that have appeared during treatment, if the failure
to make such a change might pose a threat to patient’s life,
physical integrity or health. This case covers a situation where
the consent has already been given but its scope has proved
to be insufﬁcient, and the need for going beyond that scope
occurred only during the medical intervention. The consent of
other authorised persons could not be immediately obtained.
3.  Conclusion
The change in the approach to the patient, treating them as
full-right partners and empowering them with a set of rights
under the Act on Patient Rights and Patient Ombudsman all
form a very important legislative step towards the meeting
of needs arising from practice. Hopefully, rational legislation
will go even further. Legal regulation presented in this study
still contain a number of substantial and formal imperfec-
tions. Laws regulating the issue of consent are contained in
several acts, some of which are imprecise. To be applied and
respected, law must be clear and transparent.
But it takes more  than just to revise the law. Changing the
approach to patients with cognitive deﬁcit is equally impor-
tant. On the one hand, one has to remember about the key role
of a properly obtained consent for treatment, without which
treatment may involve civil or criminal liability. On the other
hand, one has to act in the best interest of patients who, for
different reasons, are not able to manage their conduct and
take decisions of relevance to their life and health. It seems a
very good idea then to extend the competences of the e-court
to include the issuing of substitute consents by the guardian-
ship court in order to shorten and simplify the procedure. This
proposal is very important for both doctors and patients. The
issue may be well illustrated by the situation of patients with
heavy cognitive dysfunctions treated for cancer, for whom the
time of treatment onset is of paramount importance.
Conﬂict  of  interest  statement
None declared.Financial  disclosure  statement
None declared.
d rad
r
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
27. Z˙elichowski M. Without patient’s consent [in Polish].164  reports of practical oncology an
 e  f  e  r  e  n  c  e  s
1. Rymaszewska J, Kiejna A, Kustrzycki W.  Disorders of
consciousness after surgery. Adv Clin Exp Med 1999;4:385–91
[in Polish].
2. Szafryna-Kliwicka A, Litwiniuk M. Cancer
chemotherapy-induced disorders of cognitive functions.
Onkologia Polska 2011;14(3):139–45 [in Polish].
3. Petera J, Dusek L. Cancer in elderly. Rep Pract Oncol Radiother
2013;18(1):1–5.
4. Jaracz M, Borkowska A. Decision making in the light of
neurobiological studies and psychological theories.
Psychiatria 2010;7(2):68–74 [in Polish].
5. Rymaszewska J. Issues and general rules in consultative
psychiatry. Psychiatria w Praktyce Ogólnolekarskiej 2007;1(7):1–7
[in Polish].
6. Kotapka-Minc S, Szczudlik A. Standards of procedure,
dementia [in Polish]. Sekcja Psychogeriatrii i Choroby
Alzheimera Polskiego Towarzystwa Psychiatrycznego,
www.alzh.pl/standardy 2 02.html
7. Rymaszewska J. Disorders of consciousness—a challenge for
a doctor at duty. Psychiatria w praktyce klinicznej 2000;1:22–9
[in Polish].
8. Jaroszyn´ski J. Mental disorder syndromes. Warszawa: Instytut
Psychoneurologiczny; 1978. p. 8–31 [in Polish].
9. Bidzan L. Differentiation of reasons for cognitive function
disorders at old age. Geriatria 2010;4:279–83 [in Polish].
0. International Classiﬁcation of Diseases (ICD-10). 52–68,
Uniwersyteckie Wyd.Medyczne “Versalius”,
Kraków-Warszawa; 2000.
1. Bilikiewicz A, Landowski J, Radziwiłłowicz P. Psychiatry review.
Warszawa: Wyd.Lekarskie PZWL; 2006. p. 65–87 [in Polish].
2. Jaracz M, Cierpiałkowska L, Borkowska A. Operational
memory impairment and executive functions in the period of
partial remission of depressive symptoms in affective
diseases. Psychiatria 2008;5:23–9 [in Polish].
3. Walsh KW. How to understand brain damage. Basics of
neuropsychological diagnosis. Warszawa: Instytut Psychiatrii i
Neurologii; 2001 [in Polish].
4. Pa˛chalska M. Clinical neuropsychology. Brain injuries.
Communication processes and return to society [in Polish] 2:, Wyd.
Warszawa:  Naukowe PWN; 2007.
5. Jodzio K. Neuropsychological diagnosis in clinical practice.
Warszawa:  Diﬁn; 2011. p. 225–68 [in Polish].
2iotherapy 1 9 ( 2 0 1 4 ) 157–164
6. Jodzio K. Neuropsychology of intentional action. Concepts of
executive functions. Warszawa: Wydawnictwo Naukowe
Scholar; 2008 [in Polish].
7. Wciórka J, Bembenek A, Hintze B, Kuhn-Dymecka A.
Schizophrenic disorders – do cognitive dysfunctions relate to
features of psychopathologic presentation and image?
Psychiatr Pol 2006;5:867 [in Polish].
8. Patrzała A. Study on creativity of schizophrenic patients.
Doctoral dissertation under guidance of dr hab.med. Jan
Jaracz [in Polish], Uniwersytet Medyczny im. K.
Marcinkowskiego w Poznaniu, Klinika Psychiatrii Dorosłych,
11–13, Poznan´; 2010.
9. De Walden-Gałuszko K, editor. Basics of palliative care.
Warszawa: Wydawnictwo Lekarskie PZWL; 2007
[in Polish].
0. Bogusz-Osawa M, Osawa T. The inﬂuence of the European
and Polish acts of law, regulations and standards on the
forms and the contents of the informed consent for
oncological treatments. Rep Pract Oncol Radiother
2005;10(2):67–76.
1. Be˛tkowska-Korpała B, Gierowski JK, editors. Medical
psychology in treatment of somatic patients. Kraków:
Wydawnictwo Uniwersytetu Jagiellon´skiego; 1999 [in Polish].
2. Szczepan´ska-Gieracha J, Rymaszewska J. Contact with
chronic patients (neurodegenerative and cardiovascular
diseases, mental disorders). In: Steciwko A, Baran´ski J,
editors. Communication between the physician and the patient and
their family. Wrocław: Elsevier Urban & Partner; 2011 [in
Polish].
3. Fukuyama F. Our posthuman future. Kraków; 2004, p. 174.
4. Korcz I. Aggression—lifestyle challenge. In: Kowalski D,
Kwiatkowski M, Zduniak A, editors. Education for safety:
selected perspectives. Lublin: Wyd. O’CHIKARA; 2004. p. 239–54
[in Polish].
5. Staniewicz-Zalewska B. Consent for medical service in the light of
regulations arising from the provisions of the Act on Professions of
Doctor and Dentist and the Act on Health Care Institutions.
Pomorski Magazyn Lekarski; 2006. p. 190 [in Polish].
6. Justyna Zajdel J. Not every consent is valid – legal meanders of
consent for medical procedures. Przegla˛d Urologiczny; 2010. p. 63
[in  Polish].Rzeczpospolita of 4 November 1999.
8. Pyziak-Szafnicka M, editor. Civil code. General part. Comments.
2009.
